A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
Heath, E. I., Hillman, D. W., Vaishampayan, U., Sheng, S., Sarkar, F., Harper, F., Gaskins, M., Pitot, H. C., Tan, W., Ivy, S. P., Pili, R., Carducci, M. A., Erlichman, C., Liu, G.Volume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-08-0221
Date:
December, 2008
File:
PDF, 187 KB
english, 2008